These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 24693054)
1. Induced pluripotent stem (iPS) cells offer a powerful new tool for the life sciences. Nakamura Y J Stem Cells Regen Med; 2010; 6(1):2-9. PubMed ID: 24693054 [TBL] [Abstract][Full Text] [Related]
2. Development of patient-specific hematopoietic stem and progenitor cell grafts from pluripotent stem cells, in vitro. Klump H; Teichweyde N; Meyer C; Horn PA Curr Mol Med; 2013 Jun; 13(5):815-20. PubMed ID: 23642062 [TBL] [Abstract][Full Text] [Related]
3. Induced pluripotent stem cells: a new approach for physiological research. Pfannkuche K; Hannes T; Khalil M; Noghabi MS; Morshedi A; Hescheler J; Dröge P Cell Physiol Biochem; 2010; 26(2):105-24. PubMed ID: 20798495 [TBL] [Abstract][Full Text] [Related]
4. Defining hypo-methylated regions of stem cell-specific promoters in human iPS cells derived from extra-embryonic amnions and lung fibroblasts. Nishino K; Toyoda M; Yamazaki-Inoue M; Makino H; Fukawatase Y; Chikazawa E; Takahashi Y; Miyagawa Y; Okita H; Kiyokawa N; Akutsu H; Umezawa A PLoS One; 2010 Sep; 5(9):e13017. PubMed ID: 20885964 [TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling. Iglesias-García O; Pelacho B; Prósper F J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470 [TBL] [Abstract][Full Text] [Related]
6. Characterization and comparison of osteoblasts derived from mouse embryonic stem cells and induced pluripotent stem cells. Ma MS; Kannan V; de Vries AE; Czepiel M; Wesseling EM; Balasubramaniyan V; Kuijer R; Vissink A; Copray SCVM; Raghoebar GM J Bone Miner Metab; 2017 Jan; 35(1):21-30. PubMed ID: 26747612 [TBL] [Abstract][Full Text] [Related]
7. Human hair follicle pluripotent stem (hfPS) cells promote regeneration of peripheral-nerve injury: an advantageous alternative to ES and iPS cells. Amoh Y; Kanoh M; Niiyama S; Hamada Y; Kawahara K; Sato Y; Hoffman RM; Katsuoka K J Cell Biochem; 2009 Aug; 107(5):1016-20. PubMed ID: 19507228 [TBL] [Abstract][Full Text] [Related]
8. Current progress and prospects of induced pluripotent stem cells. Chen L; Liu L Sci China C Life Sci; 2009 Jul; 52(7):622-36. PubMed ID: 19641867 [TBL] [Abstract][Full Text] [Related]
9. Derivation of novel human ground state naive pluripotent stem cells. Gafni O; Weinberger L; Mansour AA; Manor YS; Chomsky E; Ben-Yosef D; Kalma Y; Viukov S; Maza I; Zviran A; Rais Y; Shipony Z; Mukamel Z; Krupalnik V; Zerbib M; Geula S; Caspi I; Schneir D; Shwartz T; Gilad S; Amann-Zalcenstein D; Benjamin S; Amit I; Tanay A; Massarwa R; Novershtern N; Hanna JH Nature; 2013 Dec; 504(7479):282-6. PubMed ID: 24172903 [TBL] [Abstract][Full Text] [Related]
10. ES and iPS cell research for cardiovascular regeneration. Yamashita JK Exp Cell Res; 2010 Oct; 316(16):2555-9. PubMed ID: 20385126 [TBL] [Abstract][Full Text] [Related]
11. Retention of Somatic Memory Associated with Cell Identity, Age and Metabolism in Induced Pluripotent Stem (iPS) Cells Reprogramming. Khoo TS; Jamal R; Abdul Ghani NA; Alauddin H; Hussin NH; Abdul Murad NA Stem Cell Rev Rep; 2020 Apr; 16(2):251-261. PubMed ID: 32016780 [TBL] [Abstract][Full Text] [Related]